Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part ii: Correlations and relationship to clinical features

Investigative Ophthalmology and Visual Science

Volumn 55, Issue 12, 2014, Pages 8173-8179

  Kupersmith, Mark J ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Intracranial hypertension; Lumbar puncture; OCT; Papilledema

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IDIOPATHIC INTRACRANIAL HYPERTENSION; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; OPTIC NERVE; PAPILLEDEMA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINAL NERVE FIBER LAYER THICKNESS; RETINAL THICKNESS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISION; VISUAL ACUITY; VISUAL FIELD; WEIGHT GAIN; CASE CONTROL STUDY; CLINICAL TRIAL; COMPLICATION; FEMALE; INTRACRANIAL HYPERTENSION; MALE; MIDDLE AGED; NERVE FIBER; OPTIC DISK; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PROCEDURES; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MIDDLE AGED; NERVE FIBERS; OPTIC DISK; PAPILLEDEMA; RETINAL GANGLION CELLS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; YOUNG ADULT;

EID: 84917708574     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-14961     Document Type: Article

References (12)

1. OCT Sub-Study Committee for the NORDIC Idiopathic Intracranial Hypertension Study Group. Baseline OCT measurements in the Idiopathic Intracranial Hypertension Treatment Trial, part I: quality control, comparisons, and variability. Invest Ophthalmol Vis Sci. 2014;8180-8188.
2. Wang J, Kardon R, Kupersmith M, et al. Automated quantification of volumetric optic disc swelling in papilledema using spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53:4069-4075.
3. Scott C, Kardon R, Lee A, Frisén L, Wall M. Diagnosis and grading of papilledema in patients with raised intracranial pressure using optical coherence tomography vs clinical expert assessment using a clinical staging scale. Arch Ophthalmol. 2010;128(6);705-711.
4. Friedman D, McDermott M, Kieburtz K, et al; for the NORDIC IIHTT Study Group. The Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): design considerations and methods. J Neuroophthalmol. 2014;34:107-117.
5. Vartin V, Nuyen A, Balmitgere T, Bernard M, Tilikete C, Vighetto A. Detection of mild papilledema using spectral domain optical coherence tomography. Br J Ophthalmol. 2012;96:375-379.
6. Heckman J, Weber M, Junemann A, Neundorfer B, Mardin C. Laser scanning tomography of the optic nerve vs CSF opening pressure in idiopathic intracranial hypertension. Neurology. 2004;62:1221-1223.
7. Kupersmith M, Sibony P, Mandel G, Durbin M, Kardon R. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary RPE layer in papilledema. Invest Ophthalmol Vis Sci. 2011;52:6558-6564.
8. Skau M, Yri H, Sander B, Gerds T, Milea D, Jensen R. Diagnostic value of optical coherence tomography for intracranial pressure in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2013;251:567-574.
9. Rebolleda G, Munoz-Negrete F. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography. Invest Ophthal Vis Sci. 2009;50:5197-5200.
10. Saikai R, Feller D, Galetta K, Galetta S, Balcer L. Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection. J Neuroophthalmol. 2011; 51:362-373.
11. Skau M, Sander B, Milea D, Jensen R. Disease activity in idiopathic intracranial hypertension: a 3-month follow-up study. J Neurol. 2011;258:277-283.
12. Skau M, Milea D, Sander B, Wegner M, Jensen R. OCT for optic disc elevation in idiopathic intracranial hypertension. Graefes Arch Clin Exp Ophthalmol. 2011;249:723-730.